These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28377968)

  • 1. Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study in the Asia-Pacific Region (MUSIC OS-AP): Design of a multinational, prospective, observational study examining the impact of gastrointestinal events on osteoporosis management in postmenopausal women.
    Modi A; Ebeling PR; Lee MS; Min YK; Mithal A; Yang X; Sajjan S
    Bone Rep; 2015 Dec; 3():61-66. PubMed ID: 28377968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of gastrointestinal events on patient-reported outcomes in Asia-Pacific women with osteoporosis: baseline results of the MUSIC OS-AP study.
    Modi A; Ebeling PR; Lee MS; Min YK; Mithal A; Yang X; Baidya S; Sen S; Sajjan S
    Arch Osteoporos; 2017 Dec; 12(1):65. PubMed ID: 28718004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and Canada.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Nguyen AM; Keown PA; Leung AT; Sajjan S
    Clin Exp Rheumatol; 2015; 33(4):537-44. PubMed ID: 26146786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver J; van den Bergh JP; Nguyen AM; Sajjan S;
    Osteoporos Int; 2016 Mar; 27(3):1227-1238. PubMed ID: 26637321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS).
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Keown PA; Sajjan S
    Osteoporos Int; 2017 Oct; 28(10):2867-2876. PubMed ID: 28643048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of gastrointestinal events on treatment of osteoporosis in Asia-Pacific women: Perspectives from physicians in the MUSIC OS-AP study.
    Modi A; Ebeling PR; Lee MS; Min YK; Mithal A; Yang X; Baidya S; Sen S; Sajjan S
    Bone Rep; 2017 Dec; 7():108-113. PubMed ID: 29062864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Keown P; Sajjan S
    Osteoporos Int; 2018 Feb; 29(2):329-337. PubMed ID: 29110061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea.
    Byun DW; Moon SH; Kim T; Lee HH; Park HM; Kang MI; Ha YC; Chung HY; Yoon BK; Kim TY; Chae SU; Shin CS; Yang KH; Lee JH; Chang JS; Kim SH; Kim IJ; Koh JM; Jung JH; Yi KW; Yoo JJ; Chung DJ; Lee YK; Yoon HK; Hong S; Kim DY; Baek KH; Kim HJ; Kim YJ; Kang S; Min YK
    J Bone Miner Metab; 2019 May; 37(3):563-572. PubMed ID: 30238428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives.
    Weaver JP; Olsson K; Sadasivan R; Modi A; Sen S
    J Womens Health (Larchmt); 2017 Dec; 26(12):1302-1311. PubMed ID: 28994642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
    Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
    Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of gastrointestinal events with osteoporosis treatment initiation and treatment compliance in Germany: An observational study.
    Modi A; Fan CS; Tang J; Weaver JP; Sajjan S
    Bone Rep; 2016 Dec; 5():208-213. PubMed ID: 28580388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women.
    Flood EM; Beusterien KM; Green H; Shikiar R; Baran RW; Amonkar MM; Cella D
    Health Qual Life Outcomes; 2006 Jul; 4():42. PubMed ID: 16834773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of the POSSIBLE UStrade mark Study: postmenopausal women's compliance and persistence with osteoporosis medications.
    Barrett-Connor E; Ensrud K; Tosteson AN; Varon SF; Anthony M; Daizadeh N; Wade S
    Osteoporos Int; 2009 Mar; 20(3):463-72. PubMed ID: 18607669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS).
    Chen CH; Elsalmawy AH; Ish-Shalom S; Lim SJ; Al-Ali NS; Cunha-Borges JL; Yang H; Casas N; Altan L; Moll T; Gurbuz S; Brnabic AJM; Burge RT; Marin F
    Curr Med Res Opin; 2019 Jun; 35(6):1041-1049. PubMed ID: 30474449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS).
    Cunha-Borges JL; Mier GM; Casas N; Medina A; Molina JF; García ML; Oliveria LG; Caselato MS; Cruz AC; Ippolito V; Flórez S
    Adv Rheumatol; 2019 Nov; 59(1):46. PubMed ID: 31703737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study.
    Woo C; Gao G; Wade S; Hochberg MC
    Curr Med Res Opin; 2010 Apr; 26(4):1003-9. PubMed ID: 20201623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-Pacific.
    Korthoewer D; Chandran M;
    Arch Osteoporos; 2012; 7():193-200. PubMed ID: 23225297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review.
    Chang Y-; Huang C-; Hwang J-; Kuo J-; Lin K-; Huang H-; Bagga S; Kumar A; Chen F-; Wu C-
    Osteoporos Int; 2018 Apr; 29(4):779-792. PubMed ID: 29285627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.